Jennifer L. Good, President & CEO at Trevi Therapeutics, Inc. (TRVI), sold 6,059 shares at $3.04 ($18K) on 2024-09-09, disclosed to the SEC on 2024-09-09.
Open-market sale of $18k TRVI by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.03 | 4,219 | $13K | 69.6% |
| 2 | $3.04 | 1,840 | $6K | 30.4% |
| Total | $3.03 avg | 6,059 | $18K | 100% |
| Filing → |
| RYTM | SELL | 2024-09-11 | $3.8M | — | Filing → |
| TRVI | SELL | 2024-09-05 | $295K | — | Filing → |
| RYTM | SELL | 2024-08-28 | $1.5M | — | Filing → |